IL100533A - Pharmaceutical preparations containing a history of xanthine for VIH treatment and disease states - Google Patents

Pharmaceutical preparations containing a history of xanthine for VIH treatment and disease states

Info

Publication number
IL100533A
IL100533A IL10053387A IL10053387A IL100533A IL 100533 A IL100533 A IL 100533A IL 10053387 A IL10053387 A IL 10053387A IL 10053387 A IL10053387 A IL 10053387A IL 100533 A IL100533 A IL 100533A
Authority
IL
Israel
Prior art keywords
formula
compounds
group
compound
alkyl
Prior art date
Application number
IL10053387A
Other languages
English (en)
Hebrew (he)
Original Assignee
Hoechst Roussel Pharma
Univ Virginia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma, Univ Virginia filed Critical Hoechst Roussel Pharma
Publication of IL100533A publication Critical patent/IL100533A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL10053387A 1986-12-31 1987-12-23 Pharmaceutical preparations containing a history of xanthine for VIH treatment and disease states IL100533A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94790586A 1986-12-31 1986-12-31

Publications (1)

Publication Number Publication Date
IL100533A true IL100533A (en) 1994-05-30

Family

ID=25486973

Family Applications (7)

Application Number Title Priority Date Filing Date
IL10685987A IL106859A (en) 1986-12-31 1987-12-23 Pentoxifilin metabolites and pharmaceutical preparations containing them for the treatment of VIH and similar diseases
IL8493487A IL84934A (en) 1986-12-31 1987-12-23 Pharmaceutical preparations containing xanthan history to stop the activity of interleukin-1 and leukocyte-derived cytokines
IL10053387A IL100533A (en) 1986-12-31 1987-12-23 Pharmaceutical preparations containing a history of xanthine for VIH treatment and disease states
IL10685487A IL106854A (en) 1986-12-31 1987-12-23 Pantoxifilin metabolites and pharmaceutical preparations containing them to prevent an immune reaction and to reduce undesirable conditions in this regard
IL10053587A IL100535A (en) 1986-12-31 1987-12-23 Pharmaceutical preparations containing a history of xanthine to relieve disease states
IL10053687A IL100536A (en) 1986-12-31 1987-12-23 Pharmaceutical preparations containing a history of xanthine Stopping an immune response and relieving adverse conditions resulting from intracellular intervention in an immune response
IL10686187A IL106861A (en) 1986-12-31 1987-12-23 Pentoxifylline metabolites and pharmaceutical formulations containing them for inhibiting the activity of interleukin-1 and leukocyte-derived cytokines

Family Applications Before (2)

Application Number Title Priority Date Filing Date
IL10685987A IL106859A (en) 1986-12-31 1987-12-23 Pentoxifilin metabolites and pharmaceutical preparations containing them for the treatment of VIH and similar diseases
IL8493487A IL84934A (en) 1986-12-31 1987-12-23 Pharmaceutical preparations containing xanthan history to stop the activity of interleukin-1 and leukocyte-derived cytokines

Family Applications After (4)

Application Number Title Priority Date Filing Date
IL10685487A IL106854A (en) 1986-12-31 1987-12-23 Pantoxifilin metabolites and pharmaceutical preparations containing them to prevent an immune reaction and to reduce undesirable conditions in this regard
IL10053587A IL100535A (en) 1986-12-31 1987-12-23 Pharmaceutical preparations containing a history of xanthine to relieve disease states
IL10053687A IL100536A (en) 1986-12-31 1987-12-23 Pharmaceutical preparations containing a history of xanthine Stopping an immune response and relieving adverse conditions resulting from intracellular intervention in an immune response
IL10686187A IL106861A (en) 1986-12-31 1987-12-23 Pentoxifylline metabolites and pharmaceutical formulations containing them for inhibiting the activity of interleukin-1 and leukocyte-derived cytokines

Country Status (14)

Country Link
EP (1) EP0279079B1 (ko)
JP (1) JP2507012B2 (ko)
KR (1) KR960015726B1 (ko)
AT (1) ATE151290T1 (ko)
AU (1) AU668982B2 (ko)
CA (1) CA1313137C (ko)
DE (1) DE3752048T2 (ko)
DK (1) DK482088A (ko)
ES (1) ES2103255T3 (ko)
GR (1) GR3024054T3 (ko)
IE (1) IE873554L (ko)
IL (7) IL106859A (ko)
WO (1) WO1988004928A1 (ko)
ZA (1) ZA879754B (ko)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196430A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5196429A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5272153A (en) * 1986-12-31 1993-12-21 Hoechst-Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
CA2058952A1 (en) * 1989-06-13 1990-12-14 Nabil Hanna Monokine activity interference
DD298051A5 (de) * 1989-08-16 1992-02-06 ��@���������@�������k�� Verfahren zur herstellung eines therapeutischen agens zur behandlung von verdauungskrankheiten
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
IL100194A0 (en) * 1990-11-30 1992-08-18 Hoechst Roussel Pharma Use of xanthines for the preparation of a medicament effective for inhibiting the effects of allograft reaction in humans
EP0490181A1 (en) * 1990-11-30 1992-06-17 Hoechst-Roussel Pharmaceuticals Incorporated Use of xanthines for preparation of a medicament having immunosuppressing activity
EP1214938A3 (en) * 1991-05-24 2003-08-06 Fred Hutchinson Cancer Research Center Modulation of cellular response to external stimuli
EP0518263A1 (en) * 1991-06-10 1992-12-16 Hoechst-Roussel Pharmaceuticals Incorporated Micropellets and a process for their manufacture
WO1993003728A1 (en) * 1991-08-27 1993-03-04 Temple University Of The Commonwealth System Of Xanthine suppression of antigen activation of t- or b-cells
WO1993008820A1 (en) * 1991-10-31 1993-05-13 The Victoria University Of Manchester Treatment of neurological conditions by an interleukin-1 inhibiting compound
AU3539795A (en) * 1994-08-25 1996-03-14 Medical University Of South Carolina Methods of treating cold symptoms using pentoxifylline
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
JP3830115B2 (ja) * 1997-10-06 2006-10-04 シャープ株式会社 液晶表示素子
TW561297B (en) * 1997-11-25 2003-11-11 Toshiba Corp Electrode wiring board subjected to counter measure against static electricity and display device using the same
JP3019053B2 (ja) * 1997-12-25 2000-03-13 日本電気株式会社 液晶表示装置及びその製造方法
JP5567503B2 (ja) 2008-02-29 2014-08-06 コンサート ファーマシューティカルズ インコーポレイテッド 置換キサンチン誘導体
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
CA2771331A1 (en) 2009-09-02 2011-03-10 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
WO2012031138A2 (en) 2010-09-01 2012-03-08 Concert Pharmaceuticals, Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3-7-dimethyl-1h-purine-2,6(3h,7h)dione
US20140296263A1 (en) 2011-07-19 2014-10-02 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
JP2015512947A (ja) 2012-04-13 2015-04-30 コンサート ファーマシューティカルズ インコーポレイテッド 置換キサンチン誘導体
WO2013159006A1 (en) 2012-04-20 2013-10-24 Concert Pharmaceuticals, Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3,7-dimethyl-1h-purine-2,6(3h,7h)-dione

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2967632D1 (en) * 1978-04-22 1986-12-04 Beecham Wuelfing Gmbh & Co Kg Use of a xanthine derivate in the manufacture of a medicament
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
GB8418430D0 (en) * 1984-07-19 1984-08-22 Beecham Wuelfing Gmbh & Co Kg Treatment

Also Published As

Publication number Publication date
CA1313137C (en) 1993-01-26
EP0279079B1 (en) 1997-04-09
AU1291892A (en) 1992-05-14
DE3752048D1 (de) 1997-05-15
IL106861A (en) 1997-02-18
DK482088D0 (da) 1988-08-30
KR890700347A (ko) 1989-04-24
AU668982B2 (en) 1996-05-23
DE3752048T2 (de) 1997-10-02
IL84934A (en) 1994-08-26
GR3024054T3 (en) 1997-10-31
IL106859A (en) 1996-10-16
DK482088A (da) 1988-10-28
EP0279079A3 (en) 1990-06-13
KR960015726B1 (ko) 1996-11-20
WO1988004928A1 (en) 1988-07-14
IL100536A (en) 1994-05-30
JPH02501829A (ja) 1990-06-21
JP2507012B2 (ja) 1996-06-12
ATE151290T1 (de) 1997-04-15
AU637542B2 (en) 1993-05-27
ES2103255T3 (es) 1997-09-16
ZA879754B (en) 1989-07-26
AU619732B2 (en) 1992-02-06
EP0279079A2 (en) 1988-08-24
IL106854A (en) 1996-05-14
AU4602793A (en) 1993-11-18
IL100535A (en) 1994-05-30
AU1150588A (en) 1988-07-27
IE873554L (en) 1988-06-30

Similar Documents

Publication Publication Date Title
EP0279079B1 (en) Purine derivatives as interleukin-1 inhibitors
US5096906A (en) Method of inhibiting the activity of leukocyte derived cytokines
US5272153A (en) Method of inhibiting the activity of leukocyte derived cytokines
US4355032A (en) 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
EP0483634B1 (en) An aminoglycoside composition having substantially reduced nephrotoxicity induced by the amino glycoside
EP0011609B2 (en) Xanthine derivatives and pharmaceutical preparations containing these derivatives for use in the treatment of chronic obstructive airway disease and cardiac disease
EP0550570A1 (en) Xanthine derivatives
EP0641344A1 (en) 8-substituted anthines as phosphodiesterase inhibitors
IL35658A (en) 2, 6 - Diamino - 9 -) B - D - Arbinopuranosil (- Purine, its preparation and use in pharmacy
JPH06100450A (ja) 免疫抑制用のキサンチン類
EP1142885A1 (en) Novel 2-(n-cyanoimino)thiazolidin-4-one derivatives
Elslager et al. Folate antagonists. 9. 2, 4-Diamino-6-[(aralkyl) alkylamino] quniazolines, a potent class of antimetabolites with prodigious antimalarial effects
EP0484785B1 (en) Use of xanthines for the preparation of a medicament effective for inhibiting the replication of human retroviruses
US5196430A (en) Method of inhibiting the activity of leukocyte derived cytokines
US4085214A (en) Stable pro-drug forms of theophylline
AU619732C (en) Method of inhibiting interleukin-1 activity
US5196429A (en) Method of inhibiting the activity of leukocyte derived cytokines
WO1988004293A1 (en) Antifolate agents
JPH07258257A (ja) 新規プリン誘導体及びその薬学的に許容される塩
AU716992B2 (en) Hydroquinone derivative and pharmaceutical use thereof
NZ232452A (en) 6-amino-9h-purin-9-yl and 2-amino-6-hydroxy-9h-purin-9-yl dideoxy nucleoside derivatives; intermediates and pharmaceutical compositions
JPS58185584A (ja) ピリド〔２，３−ｄ〕ピリミジン
EP1737836A1 (en) Antiviral agents
JPH07206686A (ja) 感染疾患の予防または治療剤
WO1994025030A1 (en) SUBSTITUTED DIOXOLO[4,5-g]FURO[3',4':6,7]INDOLIZINO[1,2-b]QUINOLINONES

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees